Bionic prosthetic device company iWalk (also known as BiOM) recently announced that the company has relaunched itself as BionX Medical Technologies, Inc. According to a company press release, the name change is meant “to better reflect its commitment to delivering bionic solutions that address critical unmet needs in the market.”
In addition to the name change, the corporate relaunch brings other changes including the addition of an executive team, product enhancements, international commercial expansion and ongoing support from reimbursement authorities including the U.S. Department of Veterans Affairs (VA) and Workers’ Compensation.
“Our company was founded to revolutionize the prosthetic device industry by providing products, based on our bionic platform, that enable patients to have more freedom in their lives. Over the last year, we have made significant progress towards achieving this goal, having fortified our corporate organization, disciplined our commercial execution and continually expanded our IP portfolio and product pipeline,” Charles S. Carignan, MD, president and CEO of BionX, said in the release. “Our new name helps communicate our commitment to offering bionic solutions that restore normalized limb function and improve quality of life. We are continually inspired by our patients who strive to achieve their greatest potential.”
BionX is in the process of executing several key growth drivers including expanded insurance reimbursement, international commercial expansion and new product introductions.